Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ZONAGEN INC | 4,292,136 | reported | 31 Oct 2008 | tx 7+154,592 |
| GenMark Diagnostics, Inc. | 197,622 | reported | 02 Feb 2018 | tx 92+1,509,297−257,953 |
| Inhibrx Biosciences, Inc. | 15,000 | reported | 28 May 2025 | tx 24+1,835,096−731,050 |
| BIODESIX INC | 5,443 | reported | 02 Jan 2026 | tx 20+957,699−177,452 |
| Inhibrx, Inc. | 0 | reported | 30 May 2024 | tx 22+95,000−3,508,360 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | BIODESIX INC | 5,443 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | BIODESIX INC | 6,354 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 15,000 | 0.00 USD | deriv |
| 20 May 2025 | GRANT_AWARD | BIODESIX INC | 42,010 | 0.00 USD | deriv |
| 20 May 2025 | GRANT_AWARD | BIODESIX INC | 68,621 | 0.00 USD | deriv |
| 27 Mar 2025 | GIFT | Inhibrx Biosciences, Inc. | 90,000 | 0.00 USD | |
| 16 Dec 2024 | GIFT | Inhibrx Biosciences, Inc. | 250,000 | 0.00 USD | |
| 16 Dec 2024 | GIFT | Inhibrx Biosciences, Inc. | 500,000 | 0.00 USD | |
| 16 Dec 2024 | GIFT | Inhibrx Biosciences, Inc. | 250,000 | 0.00 USD | |
| 06 Dec 2024 | GIFT | Inhibrx Biosciences, Inc. | 52,000 | 0.00 USD | |
| 19 Nov 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 34,843 | 14.23 USD | |
| 20 Nov 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 18,750 | 14.19 USD | |
| 20 Nov 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 18,750 | 14.19 USD | |
| 19 Nov 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 34,843 | 14.23 USD | |
| 24 Jun 2024 | GIFT | Inhibrx Biosciences, Inc. | 10,000 | 0.00 USD | |
| 24 Jun 2024 | GIFT | Inhibrx Biosciences, Inc. | 89,050 | 0.00 USD | |
| 24 Jun 2024 | GIFT | Inhibrx Biosciences, Inc. | 10,000 | 0.00 USD | |
| 05 Jun 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 8,265 | 17.89 USD | |
| 05 Jun 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 49,284 | 17.23 USD | |
| 03 Jun 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 80,738 | 17.90 USD | |
| 04 Jun 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 65,337 | 17.44 USD | |
| 04 Jun 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 23,726 | 18.24 USD | |
| 31 May 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 70,193 | 16.14 USD | first after silence |
| 03 Jun 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 46,792 | 16.61 USD | |
| 29 May 2024 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 6,250 | — |
5 purchases reported after at least 12 months of silence — most recent on 31 May 2024.